It indicated that PADI2 knockdown could inhibit the invasiveness of A2780 and SKOV3 ovarian cancer cells and enhanced the ability of Olaparib to inhibit the invasiveness of ovarian cancer cells. Here, PADI2 is linked to ovarian cancer.